Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives
T Lazarević, A Rilak, ŽD Bugarčić - European journal of medicinal chemistry, 2017 - Elsevier
Metallodrugs offer potential for unique mechanism of drug action based on the choice of the
metal, its oxidation state, the types and number of coordinated ligands and the coordination …
metal, its oxidation state, the types and number of coordinated ligands and the coordination …
Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives.
T Lazarević, A Rilak, ŽD Bugarčić - European Journal of Medicinal …, 2017 - europepmc.org
Metallodrugs offer potential for unique mechanism of drug action based on the choice of the
metal, its oxidation state, the types and number of coordinated ligands and the coordination …
metal, its oxidation state, the types and number of coordinated ligands and the coordination …
[引用][C] Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives
T Lazarević, A Rilak, ŽD Bugarčić - European Journal of Medicinal …, 2017 - cir.nii.ac.jp
Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical
uses, cytotoxicity studies and future perspectives | CiNii Research CiNii 国立情報学研究所 学術 …
uses, cytotoxicity studies and future perspectives | CiNii Research CiNii 国立情報学研究所 学術 …
Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives
B Lazarević, A Rilak, Z Bugarčić - 2017 - scidar.kg.ac.rs
© 2017 Elsevier Masson SAS Metallodrugs offer potential for unique mechanism of drug
action based on the choice of the metal, its oxidation state, the types and number of …
action based on the choice of the metal, its oxidation state, the types and number of …
Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives
T Lazarević, A Rilak… - European journal of …, 2017 - pubmed.ncbi.nlm.nih.gov
Metallodrugs offer potential for unique mechanism of drug action based on the choice of the
metal, its oxidation state, the types and number of coordinated ligands and the coordination …
metal, its oxidation state, the types and number of coordinated ligands and the coordination …
[PDF][PDF] Platinum, palladium, gold and ruthenium complexes as anticancer agents: current clinical uses, cytotoxicity studies and future perspectives
T Lazarević, A Rilakb, ŽD Bugarčićb - 2017 - academia.edu
Metallodrugs offer potential for unique mechanism of drug action based on the choice of the
metal, its oxidation state, the types and number of coordinated ligands and the coordination …
metal, its oxidation state, the types and number of coordinated ligands and the coordination …